1.1 Current evidence on the safety and efficacy of endoscopic axillary lymph node retrieval for breast cancer does not appear adequate for this procedure to be used without special arrangements for consent and for audit or research.
1.2 Clinicians wishing to undertake endoscopic axillary lymph node retrieval should take the following actions.
Inform the clinical governance leads in their Trusts.
Ensure that patients understand the uncertainty about the procedure's safety and efficacy and provide them with clear written information. In addition, use of the Institute's information for the public is recommended.
Audit and review clinical outcomes of all patients having endoscopic axillary lymph node retrieval for breast cancer.
1.3 This procedure should only be undertaken by surgeons skilled in endoscopic techniques.